Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP8 | Q6V1X1 | 14/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 9/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 7/20 | 0.43 |
| ▸ | PLAU | P00749 | 1/20 | 0.38 |
| ▸ | PLAUR | Q03405 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6824630 | 0.89 | DPP8 (0.43) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6820631 | 0.83 | DPP8 (0.44) | DPP8DPP7DPP9DPP4PLAU | |
| Trifluoroacetic Acid SCHEMBL6824636 | 0.82 | DPP4 (0.45) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6820639 | 0.82 | DPP4 (0.45) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6824315 | 0.81 | DPP8 (0.48) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6823789 | 0.79 | DPP4 (0.49) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6826281 | 0.79 | DPP4 (0.49) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6826242 | 0.78 | DPP4 (0.48) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6824018 | 0.77 | DPP7 (0.51) | DPP8DPP7DPP9DPP4 | |
| Trifluoroacetic Acid SCHEMBL6820916 | 0.77 | DPP7 (0.54) | DPP8DPP7DPP9DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004076433-A1 | DIPEPTIDYL PEPTIDASE INHIBITORS | AIC (BE) | 2004-09-10 | — | — | WO | disclosed |